Fineline Cube

Follow:
14483 Articles
Novartis' Scemblix Demonstrates Superior MMR Rates in Phase III ASC4FIRST Study
CompanyDrug

Novartis’ Scemblix Demonstrates Superior MMR Rates in Phase III ASC4FIRST Study

Tecvayli (Teclistamab) Demonstrates Positive Results in MajesTEC-5 and MajesTEC-4 Trials
CompanyDrug

Tecvayli (Teclistamab) Demonstrates Positive Results in MajesTEC-5 and MajesTEC-4 Trials

SinoPep-Allsino Biopharmaceutical Partners with Spraying Systems Co. for Peptide API Manufacturing
CompanyDeals

SinoPep-Allsino Biopharmaceutical Partners with Spraying Systems Co. for Peptide API Manufacturing

Merck's Zilovertamab Vedotin Shows 100% CR Rate in Phase II Study for DLBCL: ASH Presentation
CompanyDrug

Merck’s Zilovertamab Vedotin Shows 100% CR Rate in Phase II Study for DLBCL: ASH Presentation

Medtide Inc. Submits Second IPO Application to Hong Kong Stock Exchange
CompanyDeals

Medtide Inc. Submits Second IPO Application to Hong Kong Stock Exchange

AstraZeneca's Calquence Combo Shows 35% Reduced Risk in CLL: AMPLIFY Phase III Results
CompanyDrug

AstraZeneca’s Calquence Combo Shows 35% Reduced Risk in CLL: AMPLIFY Phase III Results

Abbisko Therapeutics Presents Positive Phase II Results for Pimicotinib in cGvHD at ASH
CompanyDrug

Abbisko Therapeutics Presents Positive Phase II Results for Pimicotinib in cGvHD at ASH

Jacobio Pharma's BET Inhibitor JAB-8263 Shows Promising Results in Myelofibrosis Phase I Study
CompanyDrug

Jacobio Pharma’s BET Inhibitor JAB-8263 Shows Promising Results in Myelofibrosis Phase I Study

Youcare Pharmaceutical Gets FDA Clearance for Herpes Zoster mRNA Vaccine YKYY026
CompanyDrug

Youcare Pharmaceutical Gets FDA Clearance for Herpes Zoster mRNA Vaccine YKYY026

Duality Biologics' DB-1311 ADC Shows Promising Results in Global Phase 1/2a Trial
CompanyDrug

Duality Biologics’ DB-1311 ADC Shows Promising Results in Global Phase 1/2a Trial

Chipscreen Biosciences' Chiauranib Phase III Trial Results for SCLC Announced
CompanyDrug

Chipscreen Biosciences’ Chiauranib Phase III Trial Results for SCLC Announced

Immunofoco's IMC002 CAR-T Therapy Receives FDA Fast Track Designation for Gastric Cancer
CompanyDrug

Immunofoco’s IMC002 CAR-T Therapy Receives FDA Fast Track Designation for Gastric Cancer